[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 6438859)

Published in Urologe A on September 01, 1984

Authors

D Schmähl, M Habs, A M Tacchi

Articles by these authors

[Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats]. Z Krebsforsch (1967) 5.30

Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) (1984) 1.50

Investigation of the tumorigenic response to benzo(a)pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J Cancer Res Clin Oncol (1981) 1.31

Occurrence of second tumors in man after anticancer drug treatment. Cancer Treat Rev (1982) 1.13

[Autochtonous animal tumors as test models for cancer chemotherapy]. Mitt Dtsch Pharm Ges Pharm Ges DDR (1970) 1.10

Toxicological assessment of seeds from Moringa oleifera and Moringa stenopetala, two highly efficient primary coagulants for domestic water treatment of tropical raw waters. East Afr Med J (1984) 1.08

Roundtable discussion: symposium: medical perspectives on passive smoking. Prev Med (1984) 1.02

High-resolution black-blood contrast-enhanced T1 weighted images for the diagnosis and follow-up of intracranial arteritis. Br J Radiol (2010) 0.97

Induction of pancreatic neoplasms by 2,2'-dioxopropyl-N-propylnitrosamine. Cancer Lett (1975) 0.95

Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin. J Cancer Res Clin Oncol (1984) 0.94

[Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents]. Arzneimittelforschung (1970) 0.92

Occurrence of second primary malignancies in man--a second look. Cancer Treat Rev (1985) 0.92

Carcinogenic action of low-dose cyclophosphamide given orally to Sprague-Dawley rats in a lifetime experiment. Int J Cancer (1979) 0.91

Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats. Anticancer Res (1989) 0.90

Investigations on carcinogenic effects of Penicillium caseicolum and P. roqueforti in rats. Experientia (1977) 0.90

Chemotherapy studies in autochthonous rat tumors intestinal cancer. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1978) 0.89

Carcinogenicity of N-nitrosodiethanolamine in rats at five different dose levels. Cancer Res (1982) 0.88

Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism. Oncology (1980) 0.86

[Experimental investigation of "syncarcinogenesis". 4. Studies of the induction of cancer in rats with the simultaneous oral administration of diethylnitrosamine and 4-dimethylaminostilbene]. Z Krebsforsch (1965) 0.85

Carcinogenesis in different animal specids by diethylnitrosamine. Experientia (1967) 0.85

[Ascorbic acid hinderance of the prenatal carcinogenic effect of ethylurea and nitrite]. Naturwissenschaften (1973) 0.85

[Reduced toxicity of dimethylnitrosamine in rats and mice after treatment with disulfiram]. Arzneimittelforschung (1971) 0.85

[New aspects of MRI for diagnostics of large vessel vasculitis and primary angiitis of the central nervous system]. Radiologe (2010) 0.85

[Thermostable antigens of melanin producing P. aeruginosa strains]. Zentralbl Bakteriol Orig (1968) 0.83

Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats. Int J Cancer (1983) 0.83

[Lack of carcinogenic effects of cyclamate, cyclohexylamine, and saccharine in rats]. Arzneimittelforschung (1973) 0.83

[Chemotherapeutic experiments with Endoxan on autochthonous benzpyrene sarcomas in rats and mice]. Z Krebsforsch (1966) 0.83

Comparison between the effects of dietary fat level and of calorie intake on methylnitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer (1987) 0.83

Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.82

Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna). Cancer (1983) 0.82

[Diabetes mellitus and breast cancer. A retrospective follow-up study]. Onkologie (1990) 0.82

Influence of nicotine on N-nitrosomethylurea-induced mammary tumors in rats. Klin Wochenschr (1984) 0.81

[Examination of polyvinylpyridine-N-oxide (PVNO) on the carcinogenic effect in rats and mice]. Arzneimittelforschung (1969) 0.81

Experimental carcinogenesis of antitumour drugs. Cancer Treat Rev (1978) 0.81

A dose-response study on urethane carcinogenesis in rats and mice. Int J Cancer (1977) 0.81

Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy. J Cancer Res Clin Oncol (1991) 0.81

Local carcinogenicity os some environmentally relevant polycyclic aromatic hydrocarbons after lifelong topical application to mouse skin. Arch Geschwulstforsch (1980) 0.81

Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256. Oncology (1988) 0.80

[Hepatotoxic and cacinogenic effect of diethylnitrosamine in swine]. Naturwissenschaften (1967) 0.80

Influence of five different postnatal lifelong treatments on the transplacental carcinogenicity of ethylnitrosourea in Sprague-Dawley rats. Cancer Lett (1976) 0.80

Investigations on the carcinogenicity of the artificial sweeteners sodium cyclamate and sodium saccharin in rats in a two-generation experiment. Arzneimittelforschung (1984) 0.80

Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer (1992) 0.80

Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions. Eur J Cancer Clin Oncol (1986) 0.80

[Effect of immunomodulation following allogeneic blood transfusion on tumor neogenesis and growth--experimental studies in rats]. Arch Geschwulstforsch (1987) 0.79

[Cancerogenic activity of diethylnitrosamine on pigs]. Z Krebsforsch (1969) 0.79

New cytostatics with experimentally different toxic profiles. Cancer Treat Rev (1987) 0.79

[Carcinogenesis and immunosuppression]. Dtsch Med Wochenschr (1971) 0.79

Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenicity in rats. Carcinogenesis (1987) 0.79

New cytostatics--more activity and less toxicity. Cancer Treat Rev (1990) 0.79

Life-span investigations for carcinogenicity of some immune-stimulating, immunodepressive and neurotropic substances in Sprague-Dawley-rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.79

[Experimental investigations in "syncarcinogenesis". VI. Addition of minimum doses of 4 different liver carcinogens in rats in liver cancer development]. Z Krebsforsch (1970) 0.79

Anticancer efficacy of 2-chloroethylnitrosocarbamoyl derivatives of L-alanine, glycine, their di- and tripeptide homologues and the respective amides in methylnitrosourea-induced rat mammary carcinoma. Br J Cancer (1989) 0.79

[Activities of the research advisory body on Smoking and Health]. MMW Munch Med Wochenschr (1980) 0.79

[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer]. Dtsch Med Wochenschr (1987) 0.79

On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations. Wien Klin Wochenschr (1986) 0.79

Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5-fluorouracil. Int J Cancer (1981) 0.78

[Influence of immunosuppressive drugs on the canceration of rat liver by diethylnitrosamine and on the induction of fibrosarcoma by 3,4 benzpyrene]. Arzneimittelforschung (1971) 0.78

Experimental investigations on the influence upon the chemical carcinogenesis. IIIrd communication: studies with 1,2-dimethylhydrazine. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1976) 0.78

[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects]. Internist (Berl) (1971) 0.78

Leukemias induced by ethylnitrosourea in Wistar rats: incidence and chemotherapy. Leuk Res (1979) 0.78

Alkyl phosphocholines: toxicity and anticancer properties. Lipids (1987) 0.78

Syncarcinogenic action of polycyclic hydrocarbons in automobile exhaust gas condensates. IARC Sci Publ (1977) 0.78

Carcinogenicity in rats of high oral doses of N-nitroso-carbaryl, a nitrosated pesticide. Cancer Lett (1976) 0.78

Development of second malignancies in rats after cure of acute leukemia L 5222 by single doses of 2-chloroethylnitrosoureas. J Cancer Res Clin Oncol (1979) 0.78

Fluoro-substituted N-nitrosamines. 5. Carcinogenicity of n-nitroso-bis-(4,4,4-trifluoro-n-butyl)amine in rats. Carcinogenesis (1982) 0.78

Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice. J Cancer Res Clin Oncol (1984) 0.78

Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats. J Cancer Res Clin Oncol (1987) 0.78

Implications of the carcinogenic hazard of low doses of three hepatocarcinogenic N-nitrosamines. Jpn J Cancer Res (1990) 0.78

[Toxicological problems of iatrogenic carcinogenesis (report) (author's transl)]. Verh Dtsch Ges Pathol (1972) 0.78

New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities? Eur J Cancer Clin Oncol (1989) 0.78

Chemotherapeutic studies on N-nitrosoacetoxymethyl-methylamine-and 1,2-dimethylhydrazine-induced colonic tumors in rats: monotherapy with 5-fluorouracil, ftorafur, CGP 6809, and CGP 15'720A. J Cancer Res Clin Oncol (1982) 0.78

Experiments on the toxicity of locoregional liver chemotherapy with 5-fluoro-2'-deoxyuridine and 5-fluorouracil in an animal model. Recent Results Cancer Res (1986) 0.77

Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals. Arzneimittelforschung (1987) 0.77

First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma. Arch Geschwulstforsch (1988) 0.77

Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine. J Neurol (2013) 0.77

What's new in mutagenicity and carcinogenicity--status of short-term assay systems as tools in genetic toxicology and carcinogenesis. Pathol Res Pract (1987) 0.77

Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats. Br J Cancer (1985) 0.77

[Experiments on neoplasm prevention by vitamin A]. Arzneimittelforschung (1972) 0.77

Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma. J Cancer Res Clin Oncol (1986) 0.77

Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors. Cancer Treat Rep (1985) 0.77

The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas. J Cancer Res Clin Oncol (1984) 0.77